Discloses bispecific antigen binding molecules comprising two Fab fragments specific to a first antigen and a second Fab fragment specific to a second antigen fused to a first Fc domain subunit. One of the Fab fragments is a crossover fab fragment with a VH-CL/VLCH1 arrangment. The bispecific antigen binding molecule does not comprise a single chain Fab fragment.